Implantable Cardioverter Defibrillator - Indications, Advantages and Risks
An Implantable Cardioverter Defibrillator is an implantable cardiac device which defibrillates the heart in case of life-threatening arrhythmias.
Source: medindia.net
📰 Device Based Therapy News
Device Based Therapy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Device Based Therapy. Real-time updates on events, politics, business and more.
Insights on the Dermatophytic Onychomycosis Treatment Global Market to 2027 - Featuring Allergan, Galderma and Moberg Pharma Among Others
Share this article Share this article ResearchAndMarkets.coms offering. The publisher brings years of research experience to the 9th edition of this report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Dermatophytic Onychomycosis Treatment Market to Reach $6.5 Billion by 2027 Amid the COVID-19 crisis, the global market for Dermatophytic Onyc...
United States South Korea Laura Wood Custom Research Valeant Pharmaceuticals International Inc Office Hours Call
Source: prnewswire.com
$3Billion Worldwide Dermatophytic Onychomycosis Treatment Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com
ResearchAndMarkets.com’s offering. The publisher brings years of research experience to the 9th edition of this report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Dermatophytic Onychomycosis Treatment Market to Reach $6.5 Billion by 2027 Amid the COVID-19 crisis, the global market for Dermatophytic Onychomycosis Treatment estimated at US...
United States South Korea Laura Wood E St Office Hours Call Novabiotics Ltd Valeant Pharmaceuticals International Inc
Source: financialbuzz.com